ACTIVE

Vico Therapeutics International

Financial year 2024 · Closed on 31/12/2024

Net result-826,4 k €+91,2 %over 1 year
Gross margin-734,5 k €-137,6 %over 1 year
Equity82,9 M €+52,6 %over 1 year
Workforce0,0 ETP

Identity

Source · BCE/KBO

Vico Therapeutics International is a Private limited company incorporated in 2020. Its registered office is in Zaventem.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0746.929.395
Incorporation
15/05/2020
Legal form
Private limited company
Registered office
Da Vincilaan 1
1930 Zaventem · FlandreSee on map
Contributed capital
95 891 481,66 €
Latest accounts
31/12/2024
Average workforce
0,0 ETP
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 5 filings

Trend over 4 financial years

2024202320222021
Income statement
Gross margin-734,5 k €-309,1 k €-417,6 k €-665,6 k €
EBITDA-735,5 k €-309,1 k €-417,6 k €-665,7 k €
Operating result-735,5 k €-309,1 k €-417,6 k €-665,7 k €
Net result-826,4 k €-9,4 M €-909,4 k €-684,6 k €
Balance sheet
Equity82,9 M €54,3 M €26,7 M €27,6 M €
Total assets83,1 M €56,8 M €42,6 M €30,1 M €
Cash18,8 M €11,7 M €5,2 M €3,4 M €
Debts203,5 k €2,4 M €15,4 M €2,5 M €
Other
Workforce0,0 ETP0,0 ETP––

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

10 active · 12 ended

Active mandates

Amy Weinfeld Schulman

Director · since 27 décembre 2023

Active
Anders Hinsby

Director · since 27 décembre 2023

Active
Felice Isabel van Weegen

Director · since 27 décembre 2023

Active
Jeroen Vangindertael

Director · since 27 décembre 2023

Active
Joshua Mandel-Brehm

Director · since 27 décembre 2023

Active
Klaus Breiner

Director · since 27 décembre 2023

Active
Martijn Kleijwegt

Director · since 27 décembre 2023

Active
Micah Mackison

Director · since 27 décembre 2023

Active
Pascal Louis Droller Rémi

Director · since 27 décembre 2023

Active
PRIMIX BIO VENTURES

Director · since 27 décembre 2023 · 0476.755.691

Represented by Luc Dochez

Active

Ended mandates

Rémi Pascal Louis Droller

Director · since 27 décembre 2023

Ended
Micah Mackison

Director · since 24 octobre 2022

Ended
PRIMIX BIO VENTURES

Director · since 18 mai 2022 · 0476.755.691

Represented by Luc Dochez

Ended
Klaus Breiner

Director · since 30 août 2021

Ended

Other companies at this address

Da Vincilaan 1 1930 Zaventem
CompanyCBE no.
0x52● Active
0798.596.941
1 MILLION● Active
1003.924.462
0801.690.944
Acceleer● Active
1013.839.545
Achievers● Active
0734.749.660
ADD - APT● Active
0473.316.349
AD-MAX● Active
1022.723.260
ADVERPRESS● Active
0820.282.874
AEG SOLUTIONS● Active
1012.626.253
0800.222.482
AGI EMEA● Bankrupt
0450.925.086
AKIKOL CONCEPT● Active
1016.135.871
ALASKA BAKKERIJ● Active
0804.161.276
ALB CONSTRUCT● Active
0802.549.591
0798.215.968
0401.864.664
0822.087.965
ALLINON● Active
1042.380.905
1005.722.130
0679.584.077

Full financial information

Source · NBB
20242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202114/05/2020
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months8 months
Filing date17/07/202508/10/202425/10/202307/07/202204/06/2021
General meeting30/06/202531/07/202406/10/202330/06/202205/05/2021
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202430/06/202517/07/2025DutchPDF
Abridged model31/12/202331/07/202408/10/2024DutchPDF
Abridged model31/12/202206/10/202325/10/2023DutchPDF
Abridged model31/12/202130/06/202207/07/2022DutchPDF
Abridged model31/12/202005/05/202104/06/2021DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

10 active · 12 ended

Active mandates

Amy Weinfeld Schulman

Director · since 27 décembre 2023

Active
Anders Hinsby

Director · since 27 décembre 2023

Active
Felice Isabel van Weegen

Director · since 27 décembre 2023

Active
Jeroen Vangindertael

Director · since 27 décembre 2023

Active
Joshua Mandel-Brehm

Director · since 27 décembre 2023

Active
Klaus Breiner

Director · since 27 décembre 2023

Active
Martijn Kleijwegt

Director · since 27 décembre 2023

Active
Micah Mackison

Director · since 27 décembre 2023

Active
Pascal Louis Droller Rémi

Director · since 27 décembre 2023

Active
PRIMIX BIO VENTURES

Director · since 27 décembre 2023 · 0476.755.691

Represented by Luc Dochez

Active

Ended mandates

Rémi Pascal Louis Droller

Director · since 27 décembre 2023

Ended
Micah Mackison

Director · since 24 octobre 2022

Ended
PRIMIX BIO VENTURES

Director · since 18 mai 2022 · 0476.755.691

Represented by Luc Dochez

Ended
Klaus Breiner

Director · since 30 août 2021

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other26/01/2026
    DIVERSEN
    PDF
  • Other21/05/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other10/02/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Capital / shares30/12/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares20/12/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Mandates10/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares08/07/2024
    KAPITAAL - AANDELEN
    PDF
  • Mandates12/02/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-826,4 k €↑
  2. 12/12/2024
    apport
  3. 12/12/2024
    reduction_capital
  4. 11/12/2024
    augmentation_capital
  5. 21/06/2024
    apport
  6. 21/06/2024
    augmentation_capital
  7. 05/06/2024
    nominationBrecht Lokere — commissaris
  8. 2023
    Annual accounts 2023-9,4 M €↓
  9. 2022
    Annual accounts 2022-909,4 k €↓
  10. 24/10/2022
    nominationMACKISON Micah — Uitvoerende Bestuurder
  11. 24/10/2022
    augmentation_capital
  12. 2021
    Annual accounts 2021-684,6 k €
  13. 15/05/2020
    IncorporationPrivate limited company